Jin Long Chen
Direktor/Vorstandsmitglied bei TENAYA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Jin Long Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.10.2016 | - |
| Independent Dir/Board Member | 01.10.2016 | - |
Karriereverlauf von Jin Long Chen
Ehemalige bekannte Positionen von Jin Long Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2008 | 04.04.2023 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | 04.04.2023 | |
| Gründer | 20.12.2007 | 04.04.2023 | |
| Präsident | 01.01.2008 | 01.11.2014 | |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2008 |
| Corporate Officer/Principal | - | 01.01.2008 | |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Jin Long Chen
| Fu Jen Catholic University | Undergraduate Degree |
| National Taiwan University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Taiwan | 3 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Jin Long Chen
- Erfahrung
